Hypertension Management Guidelines

Initial Therapy

The European Society of Cardiology recommends the use of thiazide or thiazide-like diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and calcium channel blockers (CCBs) as first-line medications for managing hypertension 1, 2, 3, 4
For most patients with hypertension, a combination of two first-line agents at low doses is recommended as initial therapy, providing more effective blood pressure control than monotherapy 2, 5
The American Heart Association recommends the use of ACE inhibitors, ARBs, CCBs, and thiazide diuretics as first-line therapy, with CCBs or thiazide diuretics being more effective for Black patients 3, 6

For Black patients, the American College of Cardiology recommends the use of CCBs or thiazide diuretics as initial therapy, as they are more effective compared to ACE inhibitors 3, 6
The European Society of Cardiology recommends the use of an ACE inhibitor or ARB as first-line therapy for patients with albuminuria (urine albumin-to-creatinine ratio ≥30 mg/g) 7, 8
For patients with diabetes and established coronary artery disease, the American Diabetes Association recommends the use of ACE inhibitors or ARBs as first-line therapy 9

For patients with BP between 130/80 mmHg and 160/100 mmHg, the European Society of Cardiology recommends starting with a single drug, while for patients with BP ≥160/100 mmHg, initial therapy with two antihypertensive medications is recommended 9, 7
The American Heart Association recommends the use of single-pill combinations to improve medication adherence 2, 7

The European Society of Cardiology defines resistant hypertension as BP ≥140/90 mmHg despite treatment with three antihypertensive drugs, including a diuretic 9
For resistant hypertension, the American College of Cardiology recommends the addition of spironolactone to existing treatment 1, 9, 8

The European Society of Cardiology found that first-line thiazide diuretics have shown superior outcomes in preventing heart failure compared to CCBs and ACE inhibitors 3
The American Heart Association found that CCBs are as effective as diuretics for reducing all cardiovascular events except heart failure 3, 4

The American College of Cardiology recommends assessing baseline cardiovascular risk and presence of comorbidities before initiating therapy 10
For most patients with confirmed hypertension, the European Society of Cardiology recommends starting with a low-dose combination of two first-line agents, preferably as a single pill 2, 5